Evidence map›Paper›PMID 29124105›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2017

Measuring brain synaptic vesicle protein 2A with positron emission tomography and [

Mohamed Ali Bahri, Alain Plenevaux, Joël Aerts, Christine Bastin, Guillaume Becker, Joël Mercier, Anne Valade, Tim Buchanan, Nathalie Mestdagh, Didier Ledoux and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies.European journal of nuclear medicine and molecular imaging · 2023
    Pooled it
  2. Detection of Focal Lesions in Epilepsy with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  3. Review
  4. Assessing non-invasive quantitative methods for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  5. Review
  6. Review
  7. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  8. Evaluation of [EJNMMI research · 2024
    Article
  9. First-in-Human Study ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  10. SV2A PET imaging in human neurodegenerative diseases.Frontiers in aging neuroscience · 2024
    Review
  11. Imaging of Synaptic Density in Neurodegenerative Disorders.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Review
  12. Article
  13. [ACS medicinal chemistry letters · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Novel Tracers and Radionuclides in PET Imaging.Radiologic clinics of North America · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mohamed Ali BahriGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
Alain PlenevauxGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
Joël AertsGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
Christine BastinGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
Guillaume BeckerGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
Joël MercierUCB Biopharma SPRL, Brussels, Belgium.
Anne ValadeUCB Biopharma SPRL, Brussels, Belgium.
Tim BuchananUCB Biopharma SPRL, Brussels, Belgium.
Nathalie MestdaghUCB Biopharma SPRL, Brussels, Belgium.
Didier LedouxService des soins intensifs généraux, CHU Liege, Liege, Belgium.
Alain SeretGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
André LuxenGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
Eric SalmonGIGA-Cyclotron Research Center, University of Liège, Liege, Belgium.
University of Liège · BEUCB Pharma (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBrain distribution of synaptic vesicle protein 2A was measured with fluorine-18 UCB-H ([

methodsImages of synaptic density were acquired in healthy volunteers (two young participants and two seniors). Input function was measured by arterial blood sampling (arterial input function) and derived from PET images using carotid activity (image-derived input function). Logan graphical analysis was used to estimate regional synaptic vesicle protein 2A distribution volume.

results[ DISCUSSION: The cerebral distribution of [

Indexed as

Alzheimer's diseaseFluorine-18NeuroimagingPETSV2ASynapse density

Identifiers

PMID29124105
PMCPMC5671624
OpenAlexW2752170792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.